Protein,Protein_definition,Disease_category,Disease,Method,Nb_SNP,OR[95%CI],P_value
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter I Certain infectious and parasitic diseases,Candidiasis,Inverse variance weighted,12,1.11 [0.70-1.77],0.660947358846728
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,Inverse variance weighted,12,1.06 [0.95-1.19],0.311246511999083
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,Inverse variance weighted,12,1.04 [0.94-1.15],0.457305301770651
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter I Certain infectious and parasitic diseases,Mycoses,Inverse variance weighted,12,1.12 [0.86-1.45],0.418388353367804
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,Inverse variance weighted,12,1.02 [0.93-1.13],0.667352158811645
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,Inverse variance weighted,12,0.39 [0.09-1.65],0.198700953394263
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter I Certain infectious and parasitic diseases,Other septicaemia,Inverse variance weighted,12,0.96 [0.78-1.19],0.717050520857261
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter I Certain infectious and parasitic diseases,Other viral diseases,Inverse variance weighted,12,1.03 [0.85-1.25],0.76478109008411
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,Inverse variance weighted,12,0.80 [0.17-3.78],0.779640964242158
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,Inverse variance weighted,12,2.23 [0.97-5.09],0.0576923096833793
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",Inverse variance weighted,12,0.97 [0.75-1.24],0.782976009969512
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,Inverse variance weighted,12,1.01 [0.79-1.29],0.942640791033218
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,Inverse variance weighted,12,1.15 [0.95-1.40],0.157942609928443
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",Inverse variance weighted,12,0.97 [0.85-1.12],0.711550417661414
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",Inverse variance weighted,12,1.31 [0.64-2.69],0.455035038819558
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",Inverse variance weighted,12,0.50 [0.28-0.90],0.0212918239197108
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,Inverse variance weighted,12,1.07 [0.76-1.51],0.704523691624575
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",Inverse variance weighted,12,1.17 [0.51-2.71],0.711570466501412
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter X Diseases of the respiratory system,Early onset COPD,Inverse variance weighted,12,0.98 [0.74-1.29],0.871707559350533
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter X Diseases of the respiratory system,Later onset COPD,Inverse variance weighted,12,1.15 [0.93-1.42],0.208042365110236
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,Inverse variance weighted,12,0.84 [0.59-1.18],0.308762593567458
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,Inverse variance weighted,12,1.72 [0.41-7.29],0.462409422269482
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,Inverse variance weighted,12,1.72 [0.54-5.48],0.359761357012794
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,Inverse variance weighted,12,0.73 [0.60-0.88],0.0011791816002031
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,Inverse variance weighted,12,1.02 [0.83-1.24],0.873166906871131
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,Inverse variance weighted,12,0.87 [0.55-1.37],0.545452861816035
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,Inverse variance weighted,12,4.75 [1.35-16.71],0.0151001820192051
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,Inverse variance weighted,12,1.17 [0.86-1.59],0.329199636225864
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,Inverse variance weighted,12,0.43 [0.16-1.12],0.084248360450706
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",Inverse variance weighted,12,1.29 [0.83-2.01],0.261929862635948
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",Inverse variance weighted,12,1.01 [0.74-1.38],0.942494130182971
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,Inverse variance weighted,12,1.12 [0.77-1.63],0.543071838307546
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,Inverse variance weighted,12,1.53 [0.64-3.68],0.338624469737793
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,Inverse variance weighted,12,1.03 [0.62-1.71],0.91597927978753
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,Inverse variance weighted,12,1.07 [0.79-1.45],0.674481466299047
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,Inverse variance weighted,12,1.43 [0.83-2.44],0.194915369236024
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,Inverse variance weighted,12,0.99 [0.66-1.50],0.966837212801315
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,Inverse variance weighted,12,0.75 [0.60-0.94],0.0117727592404622
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,Inverse variance weighted,12,1.07 [0.38-3.03],0.900452005410873
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",Inverse variance weighted,12,1.05 [0.86-1.29],0.611413840206727
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,Inverse variance weighted,12,0.98 [0.66-1.46],0.934893406405977
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,Inverse variance weighted,12,1.20 [0.72-1.99],0.478799502932583
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",Inverse variance weighted,12,1.02 [0.83-1.25],0.868075979371059
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,Inverse variance weighted,12,0.58 [0.20-1.68],0.318313153935279
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,Inverse variance weighted,12,0.72 [0.50-1.03],0.0723752609347048
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,Inverse variance weighted,12,0.83 [0.60-1.17],0.290667590486439
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,Inverse variance weighted,12,1.12 [0.81-1.56],0.488981927861936
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,Inverse variance weighted,12,1.05 [0.88-1.26],0.56380424503508
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",Inverse variance weighted,12,1.16 [0.86-1.58],0.332469572485351
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,Inverse variance weighted,12,1.03 [0.89-1.19],0.682293963628562
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,Inverse variance weighted,12,2.88 [0.62-13.42],0.177283477766671
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,Inverse variance weighted,12,0.80 [0.53-1.20],0.278568918132723
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,Inverse variance weighted,12,0.68 [0.49-0.94],0.0188524550758402
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",Inverse variance weighted,12,0.80 [0.16-4.07],0.783578923654142
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,Inverse variance weighted,12,0.99 [0.82-1.20],0.935665245911784
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,Inverse variance weighted,12,0.90 [0.39-2.07],0.806599855392661
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,Inverse variance weighted,12,0.54 [0.21-1.36],0.192509373998157
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,Inverse variance weighted,12,1.20 [0.83-1.75],0.329092491324555
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",Inverse variance weighted,12,1.12 [0.72-1.74],0.615563969473489
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,Inverse variance weighted,12,1.52 [1.00-2.32],0.0509985599438996
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,Inverse variance weighted,12,1.06 [0.96-1.17],0.248810520782867
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,Inverse variance weighted,12,1.09 [0.99-1.20],0.0931892217673024
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,Inverse variance weighted,12,1.20 [0.84-1.71],0.307202891155701
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter VI Diseases of the nervous system,Falls/tendency to fall,Inverse variance weighted,12,0.94 [0.87-1.01],0.0940716293638329
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter VI Diseases of the nervous system,Motor neuron disease,Inverse variance weighted,12,2.32 [0.96-5.58],0.0601920266344878
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,Inverse variance weighted,12,0.74 [0.53-1.03],0.0775714687903738
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,Inverse variance weighted,12,1.35 [0.59-3.09],0.478657630780783
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,Inverse variance weighted,12,0.93 [0.86-1.00],0.060261933602403
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter VI Diseases of the nervous system,Epilepsy,Inverse variance weighted,12,0.82 [0.66-1.02],0.0752427157061337
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter VI Diseases of the nervous system,Hemiplegia,Inverse variance weighted,12,0.49 [0.30-0.81],0.0054371919634971
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,Inverse variance weighted,12,1.10 [0.79-1.53],0.568358716177935
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",Inverse variance weighted,12,1.08 [0.93-1.26],0.326377776183723
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter VI Diseases of the nervous system,Other disorders of nervous system,Inverse variance weighted,12,1.01 [0.64-1.59],0.979882550890015
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter VI Diseases of the nervous system,Other neurological diseases,Inverse variance weighted,12,1.05 [0.92-1.20],0.466757710860196
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",Inverse variance weighted,12,1.02 [0.77-1.35],0.909582898360117
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",Inverse variance weighted,12,1.45 [1.08-1.95],0.0130708125549028
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter VI Diseases of the nervous system,Other sleep disorders,Inverse variance weighted,12,1.27 [0.90-1.78],0.175642145151432
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",Inverse variance weighted,12,0.97 [0.70-1.36],0.878097934959384
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),Inverse variance weighted,12,1.22 [0.78-1.93],0.382339576456685
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,Inverse variance weighted,12,0.99 [0.82-1.19],0.899421644520708
EDA2R,Tumor necrosis factor receptor superfamily member 27,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,Inverse variance weighted,12,0.91 [0.79-1.05],0.217107554456175
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,Inverse variance weighted,12,1.46 [0.96-2.23],0.0760960768818744
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,Inverse variance weighted,12,0.98 [0.88-1.08],0.637762979264575
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),Inverse variance weighted,12,1.63 [0.93-2.86],0.0860076728053526
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,Inverse variance weighted,12,0.68 [0.53-0.87],0.0018835951678697
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Angina pectoris,Inverse variance weighted,12,1.17 [0.94-1.45],0.158022476625379
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Aortic aneurysm,Inverse variance weighted,12,1.03 [0.72-1.46],0.890727449005748
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,Inverse variance weighted,12,1.66 [0.90-3.07],0.10709774275364
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,Inverse variance weighted,12,1.55 [0.79-3.07],0.203528831167354
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,Inverse variance weighted,12,1.02 [0.71-1.49],0.90082835570165
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",Inverse variance weighted,12,1.07 [0.90-1.27],0.431885820092798
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,AV-block,Inverse variance weighted,12,0.99 [0.76-1.30],0.968948671073071
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Cardiac arrest,Inverse variance weighted,12,0.88 [0.56-1.40],0.599865988584655
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Cardiomyopathy,Inverse variance weighted,12,0.69 [0.53-0.89],0.004019187272558
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",Inverse variance weighted,12,0.68 [0.46-1.01],0.0575017355142806
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",Inverse variance weighted,12,0.99 [0.64-1.53],0.952627755185574
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,Inverse variance weighted,12,1.17 [0.92-1.48],0.191306917138463
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Conduction disorders,Inverse variance weighted,12,0.89 [0.71-1.10],0.27001646853054
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,Inverse variance weighted,12,1.09 [0.89-1.33],0.396009462915679
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,"Heart failure, strict",Inverse variance weighted,12,0.91 [0.80-1.03],0.137483338386465
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Hypotension,Inverse variance weighted,12,1.16 [0.87-1.55],0.320366270111348
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,"Hypertension, essential",Inverse variance weighted,12,0.84 [0.73-0.96],0.0129145161040012
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Hypertension,Inverse variance weighted,12,0.83 [0.72-0.96],0.0110888273269756
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",Inverse variance weighted,12,0.40 [0.10-1.62],0.19865184339
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,Inverse variance weighted,12,0.79 [0.43-1.45],0.452493976607189
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",Inverse variance weighted,12,1.12 [0.94-1.33],0.194318073618066
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,Inverse variance weighted,12,1.01 [0.85-1.20],0.933284955379245
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Left bundle-branch block,Inverse variance weighted,12,1.31 [0.84-2.04],0.231650822585208
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,Inverse variance weighted,12,0.93 [0.49-1.78],0.836539358652785
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",Inverse variance weighted,12,1.24 [0.96-1.60],0.104328487615365
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Other aneurysm,Inverse variance weighted,12,1.09 [0.58-2.08],0.783042268283304
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Other arrhythmias,Inverse variance weighted,12,0.91 [0.81-1.03],0.13640715612175
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,Inverse variance weighted,12,0.65 [0.40-1.07],0.0933433374909437
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,Inverse variance weighted,12,0.94 [0.51-1.73],0.840253627658947
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,Inverse variance weighted,12,1.51 [1.00-2.27],0.0478979160661779
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,Inverse variance weighted,12,0.75 [0.61-0.93],0.007375162265814
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,Inverse variance weighted,12,0.71 [0.31-1.62],0.416062586689064
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,DVT of lower extremities,Inverse variance weighted,12,1.11 [0.90-1.38],0.329756515324949
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),Inverse variance weighted,12,1.19 [0.90-1.58],0.231521253338458
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Pulmonary embolism,Inverse variance weighted,12,1.04 [0.75-1.45],0.797474179554985
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Right bundle-branch block,Inverse variance weighted,12,0.68 [0.36-1.27],0.229236790452717
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,Inverse variance weighted,12,1.33 [0.64-2.75],0.441912257600748
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Secondary right heart disease,Inverse variance weighted,12,1.03 [0.57-1.84],0.933951488650193
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,Inverse variance weighted,12,0.99 [0.82-1.19],0.901849743927818
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",Inverse variance weighted,12,0.94 [0.80-1.11],0.480888342307809
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Varicose veins,Inverse variance weighted,12,0.88 [0.75-1.03],0.111664102222834
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Oesophageal varices,Inverse variance weighted,12,0.88 [0.35-2.22],0.79438052648517
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Other disorders of veins,Inverse variance weighted,12,0.93 [0.74-1.18],0.560919260291198
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter IX Diseases of the circulatory system,Venous thromboembolism,Inverse variance weighted,12,1.11 [0.92-1.35],0.279961627875454
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter X Diseases of the respiratory system,Interstitial lung disease,Inverse variance weighted,12,2.78 [1.36-5.68],0.0049738276329252
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),Inverse variance weighted,12,0.99 [0.75-1.29],0.912798096709252
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,Inverse variance weighted,12,3.46 [1.14-10.56],0.0289709662478462
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,Inverse variance weighted,12,0.89 [0.67-1.18],0.425338746220842
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,Inverse variance weighted,12,0.99 [0.89-1.11],0.871249932695929
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",Inverse variance weighted,12,1.01 [0.91-1.12],0.875625492541538
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter X Diseases of the respiratory system,Bronchiectasis,Inverse variance weighted,12,0.91 [0.49-1.71],0.774357115374969
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter X Diseases of the respiratory system,Emphysema,Inverse variance weighted,12,1.54 [0.99-2.41],0.0561347301067696
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,Inverse variance weighted,12,1.21 [0.90-1.63],0.19766623902343
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter X Diseases of the respiratory system,All influenza,Inverse variance weighted,12,0.92 [0.75-1.14],0.459142211504229
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter X Diseases of the respiratory system,Influenza and pneumonia,Inverse variance weighted,12,1.03 [0.94-1.12],0.538050888511731
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,Inverse variance weighted,12,0.97 [0.89-1.06],0.489791081579761
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,Inverse variance weighted,12,1.01 [0.88-1.15],0.93328735022205
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter X Diseases of the respiratory system,Other diseases of pleura,Inverse variance weighted,12,0.90 [0.74-1.09],0.289887328191973
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter X Diseases of the respiratory system,Pleural effusion,Inverse variance weighted,12,0.84 [0.59-1.18],0.314195616425172
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter X Diseases of the respiratory system,Other pleural conditions,Inverse variance weighted,12,0.82 [0.57-1.17],0.27085395763197
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter X Diseases of the respiratory system,Pleural plaque,Inverse variance weighted,12,1.39 [0.96-2.01],0.0813770251224992
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,Inverse variance weighted,12,1.09 [0.73-1.63],0.670168030900694
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter X Diseases of the respiratory system,Pneumothorax,Inverse variance weighted,12,1.04 [0.67-1.60],0.861584591839275
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter X Diseases of the respiratory system,Pulmonary oedema,Inverse variance weighted,12,1.65 [0.68-3.98],0.266907077498597
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,Inverse variance weighted,12,0.97 [0.89-1.05],0.475529101634268
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter X Diseases of the respiratory system,Viral pneumonia,Inverse variance weighted,12,0.81 [0.58-1.13],0.211612589886211
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,Inverse variance weighted,12,1.02 [0.90-1.16],0.72235950247758
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,Alcoholic liver disease,Inverse variance weighted,12,1.02 [0.67-1.55],0.929361470593317
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,Cholelithiasis,Inverse variance weighted,12,0.89 [0.77-1.03],0.121887143070076
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,Constipation,Inverse variance weighted,12,0.99 [0.88-1.10],0.795754673813976
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,Inverse variance weighted,12,1.00 [0.78-1.30],0.987693174735513
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,Other diseases of liver,Inverse variance weighted,12,0.74 [0.52-1.06],0.100549045609039
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,Inverse variance weighted,12,1.00 [0.85-1.19],0.960927011551239
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,Duodenal ulcer,Inverse variance weighted,12,1.07 [0.75-1.52],0.708973982369917
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,Inverse variance weighted,12,0.99 [0.82-1.19],0.909509983651648
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,Inverse variance weighted,12,1.28 [0.68-2.42],0.451008116415366
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,Inverse variance weighted,12,1.00 [0.81-1.24],0.983235591950094
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,Gastric ulcer,Inverse variance weighted,12,0.94 [0.69-1.28],0.696484958888324
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",Inverse variance weighted,12,1.28 [0.68-2.39],0.441362093440839
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,Inverse variance weighted,12,0.92 [0.74-1.14],0.434574171334926
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,Other diseases of intestines,Inverse variance weighted,12,0.98 [0.87-1.10],0.677320171472863
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,Diseases of liver,Inverse variance weighted,12,0.99 [0.81-1.21],0.91411462400718
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,Oesophagitis,Inverse variance weighted,12,1.43 [0.87-2.33],0.15949872256203
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",Inverse variance weighted,12,1.02 [0.93-1.13],0.633678546439545
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,Diseases of the digestive system,Inverse variance weighted,12,1.07 [0.89-1.27],0.475630797563457
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,Inverse variance weighted,12,0.92 [0.76-1.11],0.386185789614618
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,Inverse variance weighted,12,0.81 [0.50-1.30],0.378601257124635
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,Inverse variance weighted,12,0.86 [0.55-1.36],0.522665731359296
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,Inverse variance weighted,12,0.98 [0.75-1.29],0.908131961723295
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,Inverse variance weighted,12,1.09 [0.92-1.28],0.315585913039185
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),Inverse variance weighted,12,0.97 [0.76-1.23],0.790455735607854
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",Inverse variance weighted,12,0.95 [0.73-1.24],0.709585529518252
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,Inverse variance weighted,12,0.99 [0.63-1.55],0.959447676554104
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,Other diseases of pancreas,Inverse variance weighted,12,0.76 [0.48-1.21],0.249525904582871
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,Acute peritonitis,Inverse variance weighted,12,0.90 [0.58-1.42],0.660794810095959
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,Inverse variance weighted,12,1.07 [0.94-1.22],0.303313262374049
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,Inverse variance weighted,12,0.73 [0.46-1.15],0.170726690198241
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",Inverse variance weighted,12,0.99 [0.87-1.12],0.836980711992534
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter V Mental and behavioural disorders,Any mental disorder,Inverse variance weighted,12,1.08 [0.99-1.17],0.0953207142696949
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",Inverse variance weighted,12,1.09 [0.90-1.31],0.365603622135555
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,Inverse variance weighted,12,1.33 [0.81-2.18],0.260389793108288
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,Inverse variance weighted,12,0.89 [0.71-1.13],0.351718049558303
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,Inverse variance weighted,12,0.81 [0.45-1.47],0.491159888898583
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,Inverse variance weighted,12,1.09 [0.95-1.26],0.234330493364025
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,Inverse variance weighted,12,1.05 [0.88-1.25],0.620242961677889
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,Inverse variance weighted,12,0.95 [0.83-1.09],0.469100085398658
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,Inverse variance weighted,12,1.60 [0.75-3.39],0.222859984392609
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,Inverse variance weighted,12,0.93 [0.63-1.37],0.72150926006433
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,Inverse variance weighted,12,0.95 [0.72-1.25],0.699396478604764
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",Inverse variance weighted,12,0.94 [0.62-1.41],0.751299024978337
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,Inverse variance weighted,12,1.07 [0.98-1.18],0.143440464548814
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,Inverse variance weighted,12,1.12 [0.96-1.31],0.141955130881669
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,Inverse variance weighted,12,1.10 [0.95-1.28],0.193955841013555
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,Inverse variance weighted,12,1.14 [0.91-1.42],0.252443226836791
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,Inverse variance weighted,12,0.98 [0.76-1.26],0.874520110479555
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,Inverse variance weighted,12,1.02 [0.86-1.21],0.784243322229459
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,Inverse variance weighted,12,0.95 [0.64-1.42],0.812518384231807
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,Inverse variance weighted,12,0.99 [0.47-2.07],0.980463547153126
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,Inverse variance weighted,12,0.93 [0.73-1.18],0.562961847047001
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,Inverse variance weighted,12,1.19 [0.98-1.45],0.0847936124090345
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,Inverse variance weighted,12,1.27 [1.08-1.50],0.0045002131998
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,Inverse variance weighted,12,1.09 [1.01-1.18],0.0335521211079822
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",Inverse variance weighted,12,1.11 [1.03-1.21],0.0079188245505521
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,Inverse variance weighted,12,0.99 [0.74-1.34],0.970227865561012
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,Inverse variance weighted,12,1.15 [1.03-1.28],0.0115153132718266
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,Inverse variance weighted,12,0.81 [0.19-3.47],0.773890593585516
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,Inverse variance weighted,12,1.20 [1.04-1.39],0.0116280302825998
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,Inverse variance weighted,12,1.11 [0.97-1.28],0.134245228056412
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,Inverse variance weighted,12,1.25 [0.82-1.90],0.305296266010913
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,Inverse variance weighted,12,1.12 [0.98-1.30],0.103872542487743
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,Inverse variance weighted,12,0.96 [0.61-1.51],0.852645321896277
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,Inverse variance weighted,12,1.08 [0.82-1.43],0.578929237605468
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,Inverse variance weighted,12,1.09 [0.98-1.22],0.116313202372909
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,Inverse variance weighted,12,1.06 [0.90-1.25],0.50313111243455
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,Inverse variance weighted,12,1.15 [0.90-1.46],0.266608775716929
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,Inverse variance weighted,12,1.21 [1.01-1.45],0.0374198881453529
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [SjÂšgren],Inverse variance weighted,12,0.97 [0.66-1.43],0.881253196824127
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,Inverse variance weighted,12,1.15 [1.04-1.28],0.0086871540959342
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,Inverse variance weighted,12,1.59 [0.96-2.61],0.0711274924994609
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",Inverse variance weighted,12,1.20 [1.02-1.41],0.0269449094048668
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,Inverse variance weighted,12,1.17 [0.98-1.40],0.0916457183394447
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,Inverse variance weighted,12,1.10 [0.97-1.24],0.125459359206544
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,Inverse variance weighted,12,1.21 [1.05-1.40],0.0107133968801805
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),Inverse variance weighted,12,1.32 [0.64-2.72],0.453791673897696
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",Inverse variance weighted,12,1.23 [0.19-7.84],0.830127413417323
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIV Diseases of the genitourinary system,Acute renal failure,Inverse variance weighted,12,1.26 [0.95-1.67],0.104148585800366
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,Inverse variance weighted,12,0.90 [0.44-1.83],0.765935237495626
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,Inverse variance weighted,12,1.05 [0.85-1.29],0.641546645261484
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIV Diseases of the genitourinary system,Dialysis,Inverse variance weighted,12,1.44 [0.69-2.98],0.327592576323767
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,Inverse variance weighted,12,1.10 [0.78-1.54],0.57855692438779
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,Inverse variance weighted,12,0.62 [0.42-0.91],0.0148061875591685
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,Inverse variance weighted,12,1.14 [0.83-1.56],0.412926642309023
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,Inverse variance weighted,12,0.30 [0.16-0.57],0.000269832437671
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,Inverse variance weighted,12,0.35 [0.09-1.34],0.124306331910906
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,Inverse variance weighted,12,1.00 [0.90-1.11],0.973483767967715
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,Inverse variance weighted,12,1.19 [0.81-1.74],0.374624784104904
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",Inverse variance weighted,12,1.18 [0.78-1.80],0.433359013654389
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,Inverse variance weighted,12,1.00 [0.89-1.13],0.979963471044635
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,Inverse variance weighted,12,0.98 [0.88-1.09],0.725166508475741
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,Inverse variance weighted,12,1.09 [0.88-1.35],0.409983762115392
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,Inverse variance weighted,12,1.21 [0.85-1.73],0.286148741005534
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",Inverse variance weighted,12,1.16 [0.90-1.48],0.245891392959449
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter VI Diseases of the nervous system,Small fibre neuropathy,Inverse variance weighted,12,1.02 [0.45-2.31],0.968976140055019
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter V Mental and behavioural disorders,Smoking dependency,Inverse variance weighted,12,1.34 [0.89-2.02],0.163764727232501
EDA2R,Tumor necrosis factor receptor superfamily member 27,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",Inverse variance weighted,12,0.65 [0.39-1.09],0.103442329585317
